Ponatinib Treatment in CML and Ph plus ALL Patients: Real-Life Data from the Czech Registries

被引：0
|
作者：
Koritakova, Eva
Doubek, Michael
Faber, Edgar
Zackova, Daniela
Horacek, Jan M.
Belohlavkova, Petra
Cmunt, Eduard
Folber, Frantisek
Jindra, Pavel
Klamova, Hana
Koristek, Zdenek
Stejskal, Lukas
Szotkowski, Tomas
Salek, Cyril
Kellnerova, Renata
Chrapava, Marika
机构：
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126395
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5905
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TREATMENT OF PATIENTS WITH RARE BLEEDING DISORDERS IN THE NETHERLANDS: REAL-LIFE DATA FROM THE RBIN STUDY
    Maas, D.
    Saes, J.
    Meijer, K.
    Cnossen, M.
    Schutgens, R.
    Peters, M.
    Nieuwenhuizen, L.
    den Exter, P.
    Kruis, I.
    van Heerde, W.
    Schols, S.
    HAEMOPHILIA, 2021, 27 : 166 - 167
  • [32] Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
    A. Luna
    L. Pérez-Lamas
    C. Boque
    P. Giraldo
    B. Xicoy
    C. Ruiz Nuño
    M. Moreno Vega
    A. Alvarez-Larrán
    A. Salamanca
    A. García-Noblejas
    F. Vall-Llovera
    L. Villalon
    N. De las Heras
    E. Ramila
    M. Pérez-Encinas
    B. Cuevas
    R. Perez-Lopez
    F. Sanchez-Guijo
    A. Jiménez-Velasco
    S. Lakhwani
    L. Felipe Casado
    A. Rosell
    A. Escola
    M. J. Fernández
    C. Garcia-Hernandez
    C. Cervero
    E. Mora
    M. Sagüés
    S. Suarez-Varela
    P. Vélez
    P. Carrascosa Mastell
    R. F. Bitaube
    L. Serrano
    M. Cortes
    J.A Vera Goñi
    J. L. Steegmann
    V. Gomez Garcia de Soria
    J. M. Alonso-Dominguez
    M. Colorado Araujo
    A. Paz Coll
    J.C Hernandez-Boluda
    V. García-Gutiérrez
    Annals of Hematology, 2022, 101 : 2263 - 2270
  • [33] Real-life AE data from EudraVigilance
    Reactions Weekly, 2021, 1878 (1) : 10 - 10
  • [34] PACE: A PIVOTAL PHASE 2 TRIAL OF PONATINIB IN PATIENTS WITH CML AND PH plus ALL RESISTANT OR INTOLERANT TO DASATINIB OR NILOTINIB, OR WITH THE T315I MUTATION
    Cortes, J.
    Kim, D. W.
    Pinilla, J.
    Paquette, R.
    Le Coutre, P.
    Chuah, C.
    Nicolini, F.
    Apperley, J.
    Khoury, J.
    Talpaz, M.
    DiPersio, J.
    D'Angelo, D.
    Rea, D.
    Abruzzese, E.
    Mueller, M.
    Baccarani, M.
    Gambacorti-Passerini, C.
    Christopher, C.
    Haluska, F.
    Kantarjian, H.
    HAEMATOLOGICA, 2012, 97 : 453 - 453
  • [35] Certolizumab pegol in the treatment of psoriasis: Real-life data
    Turkmen, Meltem
    Dogan, Sinan
    DERMATOLOGIC THERAPY, 2021, 34 (03)
  • [36] Real-life data on Selexipag for the treatment of pulmonary hypertension
    Barnikel, Michaela
    Kneidinger, Nikolaus
    Klenner, Friederike
    Waelde, Andrea
    Arnold, Paola
    Sonneck, Torben
    Behr, Juergen
    Neurohr, Claus
    Milger, Katrin
    PULMONARY CIRCULATION, 2019, 9 (01)
  • [37] Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
    Luna, A.
    Perez-Lamas, L.
    Boque, C.
    Giraldo, P.
    Xicoy, B.
    Ruiz Nuno, C.
    Moreno Vega, M.
    Alvarez-Larran, A.
    Salamanca, A.
    Garcia-Noblejas, A.
    Vall-Llovera, F.
    Villalon, L.
    De Las Heras, N.
    Ramila, E.
    Perez-Encinas, M.
    Cuevas, B.
    Perez-Lopez, R.
    Sanchez-Guijo, F.
    Jimenez-Velasco, A.
    Lakhwani, S.
    Felipe Casado, L.
    Rosell, A.
    Escola, A.
    Fernandez, M. J.
    Garcia-Hernandez, C.
    Cervero, C.
    Mora, E.
    Sagues, M.
    Suarez-Varela, S.
    Velez, P.
    Carrascosa Mastell, P.
    Bitaube, R. F.
    Serrano, L.
    Cortes, M.
    Vera Goni, J. A.
    Steegmann, J. L.
    Garcia de Soria, V. Gomez
    Alonso-Dominguez, J. M.
    Colorado Araujo, M.
    Paz Coll, A.
    Hernandez-Boluda, J. C.
    Garcia-Gutierrez, V
    ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2263 - 2270
  • [38] Real-life data of ten years with omalizumab treatment
    Karayazi, Damla Gunduz
    Simsek, Gokcen Omeroglu
    Sevinc, Can
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan
    Takahashi, Naoto
    Kondo, Takeshi
    Ikari, Yuji
    Fukumoto, Yoshihiro
    Hatake, Kiyohiko
    Masunari, Akira
    Nishibayashi, Seiji
    Kageyama, Akiko
    Fukuta, Yasuhiko
    Tojo, Arinobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 930 - 938
  • [40] The Safety of Drug Treatment in Patients with Neuropathic Pain: Data from Ambulatory Care in a Real-Life Setting
    Vocca, Cristina
    Rania, Vincenzo
    Siniscalchi, Antonio
    Palleria, Caterina
    Marciano, Gianmarco
    Galati, Cecilia
    Catarisano, Luca
    Mastrangelo, Valentina
    Corasaniti, Franco
    Monea, Francesco
    Muraca, Lucia
    Citraro, Rita
    D'Agostino, Bruno
    Gallelli, Luca
    De Sarro, Giovambattista
    REPORTS, 2023, 6 (04)
12345